Oxford Vaccine Commences Phase 3 Study Moving to Sassoon General Hospital in Pune

Oxford Vaccine Commences Phase 3 Study Moving to Sassoon General Hospital in Pune

Although the AstraZeneca AZD1222 COVID-19 vaccine trial remains on hold in the United States, its full speed ahead for the underlying Oxford-created vaccine in the UK and India. For example, the COVID-19 vaccine, known as ‘Covishield’ in India, will start next week at Sassoon General Hospital in Pune in the State of Maharashtra, according to a comment from Dr. Muralidhar Tambe, professor and head of the medical school this past Saturday. The “Oxford” vaccine has been considered one of the most promising of all the leading vaccine candidates.

COVID-19 in Maharashtra

Maharashtra lies in the western peninsular region of India taking up a significant portion of the Deccan Plateau. With 123 million inhabitants, it represents the second most populated state in India.

According to some reports, this coastal state has recorded 1.21 million cases. With nearly 7 million, Pune has recorded 263,715 COVID-19 cases.   


The Phase 3 trial testing the “Covishield’ vaccine commences at Sassoon General Hospital next week, reports The Hindu. Apparently the hospital is already enrolling volunteers for the study. Manufactured by perhaps the busiest vaccine ma...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee